Showing 1 - 15 results of 15 for search 'Benjamin G. Bitler', query time: 0.04s
Refine Results
-
1
-
2
-
3
Claudin-4 localization in epithelial ovarian cancer by Margaret C. Neville, Patricia G. Webb, Heidi K. Baumgartner, Benjamin G. Bitler
Published 2022-10-01
Article -
4
SPF: A spatial and functional data analytic approach to cell imaging data. by Thao Vu, Julia Wrobel, Benjamin G Bitler, Erin L Schenk, Kimberly R Jordan, Debashis Ghosh
Published 2022-06-01
Article -
5
On clustering for cell-phenotyping in multiplex immunohistochemistry (mIHC) and multiplexed ion beam imaging (MIBI) data by Souvik Seal, Julia Wrobel, Amber M. Johnson, Raphael A. Nemenoff, Erin L. Schenk, Benjamin G. Bitler, Kimberly R. Jordan, Debashis Ghosh
Published 2022-06-01
Article -
6
-
7
Small cell carcinoma of the ovary hypercalcemic type (SCCOHT): A review and novel case with dual germline SMARCA4 and BRCA2 mutations by Brooke E. Sanders, Rebecca Wolsky, Elizabeth S. Doughty, Kristen L. Wells, Debashis Ghosh, Lisa Ku, Joseph G. Pressey, Benjamin G. Bitler, Lindsay W. Brubaker
Published 2022-12-01
Article -
8
-
9
Suppression of Nucleotide Metabolism Underlies the Establishment and Maintenance of Oncogene-Induced Senescence by Katherine M. Aird, Gao Zhang, Hua Li, Zhigang Tu, Benjamin G. Bitler, Azat Garipov, Hong Wu, Zhi Wei, Stephan N. Wagner, Meenhard Herlyn, Rugang Zhang
Published 2013-04-01
Article -
10
BET Bromodomain Inhibition Synergizes with PARP Inhibitor in Epithelial Ovarian Cancer by Sergey Karakashev, Hengrui Zhu, Yuhki Yokoyama, Bo Zhao, Nail Fatkhutdinov, Andrew V. Kossenkov, Andrew J. Wilson, Fiona Simpkins, David Speicher, Dineo Khabele, Benjamin G. Bitler, Rugang Zhang
Published 2017-12-01
Article -
11
Ovarian cancer think tank: An overview of the current status of ovarian cancer screening and recommendations for future directions by Julia M. Dexter, Lindsay W. Brubaker, Benjamin G. Bitler, Barbara A. Goff, Usha Menon, Katherine N. Moore, Karthik M. Sundaram, Christine S. Walsh, Saketh R. Guntupalli, Kian Behbakht
Published 2024-06-01
Article -
12
SWI/SNF catalytic subunits’ switch drives resistance to EZH2 inhibitors in ARID1A-mutated cells by Shuai Wu, Nail Fatkhutdinov, Takeshi Fukumoto, Benjamin G. Bitler, Pyoung Hwa Park, Andrew V. Kossenkov, Marco Trizzino, Hsin-Yao Tang, Lin Zhang, Alessandro Gardini, David W. Speicher, Rugang Zhang
Published 2018-10-01
Article -
13
BET Bromodomain Inhibition Promotes Anti-tumor Immunity by Suppressing PD-L1 Expression by Hengrui Zhu, Fee Bengsch, Nikolaos Svoronos, Melanie R. Rutkowski, Benjamin G. Bitler, Michael J. Allegrezza, Yuhki Yokoyama, Andrew V. Kossenkov, James E. Bradner, Jose R. Conejo-Garcia, Rugang Zhang
Published 2016-09-01
Article -
14
CARM1-expressing ovarian cancer depends on the histone methyltransferase EZH2 activity by Sergey Karakashev, Hengrui Zhu, Shuai Wu, Yuhki Yokoyama, Benjamin G. Bitler, Pyoung-Hwa Park, Jeong-Heon Lee, Andrew V. Kossenkov, Krutika Satish Gaonkar, Huihuang Yan, Ronny Drapkin, Jose R. Conejo-Garcia, David W. Speicher, Tamas Ordog, Rugang Zhang
Published 2018-02-01
Article -
15
Multi-Omic Approaches Identify Metabolic and Autophagy Regulators Important in Ovarian Cancer Dissemination by Lindsay J. Wheeler, Zachary L. Watson, Lubna Qamar, Tomomi M. Yamamoto, Brandon T. Sawyer, Kelly D. Sullivan, Santosh Khanal, Molishree Joshi, Veronique Ferchaud-Roucher, Harry Smith, Lauren A. Vanderlinden, Sky W. Brubaker, Cecilia M. Caino, Hyunmin Kim, Joaquin M. Espinosa, Jennifer K. Richer, Benjamin G. Bitler
Published 2019-09-01
Article